JPMORGAN CHASE & CO - NEPHROGENEX INC ownership

NEPHROGENEX INC's ticker is NRXGQ and the CUSIP is 640667101. A total of 13 filers reported holding NEPHROGENEX INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of NEPHROGENEX INC
ValueSharesWeighting
Q1 2016$15,000
-70.0%
31,5360.0%0.00%
Q4 2015$50,000
-53.3%
31,5360.0%0.00%
Q3 2015$107,00031,5360.00%
Other shareholders
NEPHROGENEX INC shareholders Q3 2015
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,052,966$3,559,0001.18%
TURNER INVESTMENTS LLC 369,188$1,248,0000.25%
Visium Asset Management, LP 790,000$2,670,0000.04%
Vantage Investment Advisors, LLC 3,700$13,0000.01%
Edge Wealth Management LLC 500$2,0000.00%
BANK OF AMERICA CORP /DE/ 11,100$38,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 40,911$138,0000.00%
BlackRock Investment Management, LLC 813$3,0000.00%
VANGUARD GROUP INC 101,426$342,0000.00%
CITIGROUP INC 101$00.00%
View complete list of NEPHROGENEX INC shareholders